Similar articles

• Tissue pharmacokinetics, inhibition of DNA synthesis and tumor cell kill after high-dose methotrexate in murine tumor models.

  Sirotnak FM, Donsbach RC, Dorick DM, Moccio DM. Sirotnak FM, et al. Cancer Res. 1976 Dec;36(12):4672-8. Cancer Res. 1976. PMID: 1000510
• Biochemical and pharmacokinetic effects of leucovorin after high-dose methotrexate in a murine leukemia model.

  Sirotnak FM, Donsbach RC, Moccio DM, Dorick DM. Sirotnak FM, et al. Cancer Res. 1976 Dec;36(12):4679-86. Cancer Res. 1976. PMID: 1087182
• Optimization of high-dose methotrexate with leucovorin rescue therapy in the L1210 leukemia and sarcoma 180 murine tumor models.

  Sirotnak FM, Moccio DM, Dorick DM. Sirotnak FM, et al. Cancer Res. 1978 Feb;38(2):345-53. Cancer Res. 1978. PMID: 304375
• High-dose methotrexate with folinic acid rescue.

  Bender JF, Grove WR, Fortner CL. Bender JF, et al. Am J Hosp Pharm. 1977 Sep;34(9):961-5. Am J Hosp Pharm. 1977. PMID: 333910 Review.
• Methotrexate. II. Use in pediatric chemotherapy.

  Lippens RJ. Lippens RJ. Am J Pediatr Hematol Oncol. 1984 Winter;6(4):397-413. Am J Pediatr Hematol Oncol. 1984. PMID: 6398630 Review.